About Ocello
Ocello: Revolutionizing Drug Discovery with Innovative Technologies
Ocello is a leading biotechnology company that specializes in developing innovative technologies for drug discovery. The company has been at the forefront of the industry for over a decade, providing cutting-edge solutions to pharmaceutical and biotech companies worldwide. In 2019, Ocello became part of Crown Bioscience, a global leader in preclinical services and translational research.
Ocello's mission is to accelerate drug discovery by providing reliable and cost-effective solutions that enable researchers to make informed decisions early in the drug development process. The company's proprietary technology platform, known as Cellario®, allows researchers to automate complex cell-based assays and generate high-quality data quickly and efficiently.
Cellario® is an advanced robotic system that integrates multiple instruments into a single platform, enabling researchers to perform complex experiments with ease. The system can handle various types of assays, including cell viability assays, proliferation assays, apoptosis assays, and more. With Cellario®, researchers can run multiple experiments simultaneously while maintaining high accuracy and reproducibility.
One of Ocello's key strengths is its ability to customize its technology platform according to the specific needs of its clients. The company works closely with its customers to understand their requirements and develop tailored solutions that meet their unique needs. This approach has helped Ocello establish long-term partnerships with some of the world's leading pharmaceutical companies.
Ocello also offers a range of other services designed to support drug discovery efforts. These include assay development services, compound screening services, hit-to-lead optimization services, toxicity testing services, and more. By leveraging its expertise in automation technology and assay development, Ocello helps clients accelerate their drug discovery programs while reducing costs.
In addition to its core business activities, Ocello is committed to advancing scientific knowledge through research collaborations with academic institutions worldwide. The company collaborates with leading scientists in various fields such as cancer research, neuroscience, and immunology to develop new assays and technologies that can help advance drug discovery.
Ocello's commitment to innovation and excellence has earned it a reputation as a trusted partner in the pharmaceutical industry. The company's technology platform has been used in numerous drug discovery programs, resulting in the identification of several promising drug candidates. Ocello's expertise in automation technology and assay development has helped its clients reduce costs, increase efficiency, and accelerate their drug discovery efforts.
In conclusion, Ocello is a leading biotechnology company that is revolutionizing drug discovery with innovative technologies. Its proprietary technology platform Cellario® enables researchers to automate complex cell-based assays quickly and efficiently while maintaining high accuracy and reproducibility. The company's commitment to customization ensures that its solutions meet the unique needs of its clients. With its expertise in automation technology and assay development, Ocello is helping pharmaceutical companies worldwide accelerate their drug discovery programs while reducing costs.